|Event Name||IBC Life Sciences 2012 Cell Therapy Bioprocessing
Tuesday, September 11, 2012
Wednesday, September 12, 2012
Doubletree Crystal City
|Description||The tone for the conference was set early as Dr. Robert Willenbucher and Dr. Kurt Gunter delivered great keynotes that examined the current trends and future directions of the cell therapy market. They were followed by Dr. Donald Fink of the FDA, who delivered a featured presentation on a CMC reviewer's perspective on overcoming the challenge of manufacturing a deliverable cell therapy product and Dr. Paula Salmikangas of the Finnish Medicines Agency to give the European perspective on manufacturing and testing cell-based medicinal products. The focus then shifted to development and product characterization, upstream process development and downstream process development as presenters shared exclusive case studies and unpublished data with attendees. Day one concluded with a festive cocktail reception which was constantly buzzing with activity as our attendees met with product and service providers and discussed the results from their latest research.
|Host Company||IBC Life Sciences